Lars Rombo

3.6k total citations
47 papers, 1.4k citations indexed

About

Lars Rombo is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lars Rombo has authored 47 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 17 papers in Infectious Diseases and 17 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lars Rombo's work include Hepatitis Viruses Studies and Epidemiology (11 papers), Viral gastroenteritis research and epidemiology (9 papers) and Travel-related health issues (7 papers). Lars Rombo is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (11 papers), Viral gastroenteritis research and epidemiology (9 papers) and Travel-related health issues (7 papers). Lars Rombo collaborates with scholars based in Sweden, Belgium and Finland. Lars Rombo's co-authors include Jane N. Zuckerman, Anu Kantele, Karlis Pauksens, Helena Hervius Askling, Sirkka Vene, Jan Hendrik Richardus, Tino F. Schwarz, Roman Chlíbek, Thomas C. Heineman and Georg Plassmann and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and PEDIATRICS.

In The Last Decade

Lars Rombo

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Rombo Sweden	23	615	455	426	240	189	47	1.4k
Birgitte Giersing Switzerland	25	636 1.0×	502 1.1×	700 1.6×	95 0.4×	304 1.6×	77	2.0k
Todd F. Hatchette Canada	31	1.2k 2.0×	279 0.6×	1.3k 3.0×	465 1.9×	238 1.3×	139	2.7k
P.A.C. Maple United Kingdom	23	829 1.3×	118 0.3×	602 1.4×	74 0.3×	145 0.8×	59	1.7k
Usa Thisyakorn Thailand	28	662 1.1×	1.5k 3.2×	1.5k 3.4×	157 0.7×	126 0.7×	157	2.5k
Filip Dubovsky United States	29	1.5k 2.5×	362 0.8×	983 2.3×	81 0.3×	332 1.8×	53	2.6k
Jin Han Kang South Korea	24	984 1.6×	243 0.5×	693 1.6×	59 0.2×	105 0.6×	203	2.0k
Serign J. Ceesay Gambia	18	450 0.7×	706 1.6×	229 0.5×	214 0.9×	342 1.8×	23	1.5k
Lucina Titone Italy	25	750 1.2×	517 1.1×	887 2.1×	382 1.6×	298 1.6×	76	1.9k
Karl–Heinz Herbinger Germany	20	484 0.8×	295 0.6×	494 1.2×	123 0.5×	54 0.3×	47	1.1k
Kee Tai Goh Singapore	23	792 1.3×	531 1.2×	924 2.2×	42 0.2×	141 0.7×	53	2.2k

Countries citing papers authored by Lars Rombo

Since Specialization

Citations

This map shows the geographic impact of Lars Rombo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Rombo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Rombo more than expected).

Fields of papers citing papers by Lars Rombo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Rombo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Rombo. The network helps show where Lars Rombo may publish in the future.

Co-authorship network of co-authors of Lars Rombo

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Rombo. A scholar is included among the top collaborators of Lars Rombo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Rombo. Lars Rombo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mero, Sointu, Tinja Lääveri, Johan Ursing, et al.. (2023). Seasonal variation of diarrhoeal pathogens among Guinea-Bissauan children under five years of age. PLoS neglected tropical diseases. 17(3). e0011179–e0011179. 3 indexed citations

Ekre, Hans-Peter T., et al.. (2023). Safety and tolerability of frozen, capsulized autologous faecal microbiota transplantation. A randomized double blinded phase I clinical trial. PLoS ONE. 18(9). e0292132–e0292132. 4 indexed citations

Mero, Sointu, Tinja Lääveri, Sandra Valborg Løfberg, et al.. (2021). Prevalence of diarrhoeal pathogens among children under five years of age with and without diarrhoea in Guinea-Bissau. PLoS neglected tropical diseases. 15(9). e0009709–e0009709. 19 indexed citations

Wilkinson, Tom, Stuart Schembri, Christopher E. Brightling, et al.. (2019). Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial. Vaccine. 37(41). 6102–6111. 41 indexed citations

Albinsson, Bo, Sirkka Vene, Lars Rombo, et al.. (2018). Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017. Eurosurveillance. 23(3). 32 indexed citations

Leung, Ting Fan, Fong Seng Lim, Franck Thollot, et al.. (2017). Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9–14 years: Results to month 36 from a randomized trial. Vaccine. 36(1). 98–106. 22 indexed citations

Herzog, Christian, et al.. (2017). An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression – A prospective, open-label, multi-center study. Travel Medicine and Infectious Disease. 21. 43–50. 26 indexed citations

Leung, Ting Fan, Fong Seng Lim, Franck Thollot, et al.. (2015). Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial. Human Vaccines & Immunotherapeutics. 11(7). 1689–1702. 41 indexed citations

Rombo, Lars, et al.. (2014). Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study. Travel Medicine and Infectious Disease. 12(2). 134–142. 50 indexed citations

10.

Pakkanen, Sari H., et al.. (2014). Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly. Vaccine. 33(3). 451–458. 16 indexed citations

11.

Erra, Elina, Helena Hervius Askling, Sutee Yoksan, et al.. (2013). Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up study. Vaccine. 32(1). 119–123. 27 indexed citations

12.

Gabutti, Giovanni, H. C. Rümke, Lars Rombo, et al.. (2012). Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine Manufactured With Recombinant Human Albumin. The Pediatric Infectious Disease Journal. 31(11). 1166–1172. 7 indexed citations

13.

Erra, Elina, Helena Hervius Askling, Sutee Yoksan, et al.. (2012). Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes. Clinical Infectious Diseases. 56(2). 267–270. 60 indexed citations

14.

Peeters, Mathieu, et al.. (2012). Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: Data from two multicentre randomised trials. Vaccine. 30(45). 6483–6491. 12 indexed citations

15.

Erra, Elina, Helena Hervius Askling, Lars Rombo, et al.. (2012). A Single Dose of Vero Cell-Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain-Derived JE Vaccines. Clinical Infectious Diseases. 55(6). 825–834. 28 indexed citations

16.

Marshall, Helen, Terry Nolan, Javier Díez‐Domingo, et al.. (2010). Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1–11 years. Vaccine. 28(27). 4411–4415. 11 indexed citations

17.

DuPont, Herbert L., Charles D. Ericsson, Michael J.G. Farthing, et al.. (2009). Expert Review of the Evidence Base for Prevention of Travelers’ Diarrhea. Journal of Travel Medicine. 16(3). 149–160. 77 indexed citations

18.

DuPont, Herbert L., Charles D. Ericsson, Michael J.G. Farthing, et al.. (2009). Expert Review of the Evidence Base for Self‐Therapy of Travelers’ Diarrhea. Journal of Travel Medicine. 16(3). 161–171. 52 indexed citations

19.

Bronner, Ulf, et al.. (1994). Long term exposure of Trypanosoma brucei gambiense to pentamidine in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene. 88(3). 332–333. 10 indexed citations

20.

Bergqvist, Yngve, et al.. (1990). Evaluation of Test Sensitivity and Test Specificity of Three Field Methods for Quantification of Chloroquine in Urine Using Liquid Chromatography as Reference Method. Therapeutic Drug Monitoring. 12(4). 366–372. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact